Novo bolsters R&D pipeline with RNAi therapies from DicernaNovo Nordisk has further bolstered its liver disease R&D pipeline, signing a deal with US biotech Dicerna to Share XNovo bolsters R&D pipeline with RNAi therapies from Dicernahttps://pharmaphorum.com/news/novo-bolsters-rd-pipeline-with-rnai-therapies-from-dicerna/